Nexalin Short Long Term Debt Total vs Total Stockholder Equity Analysis

NXL Stock

USD 3.82 0.08 2.05%

Nexalin Technology financial indicator trend analysis is infinitely more than just investigating Nexalin Technology recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nexalin Technology is a good investment. Please check the relationship between Nexalin Technology Short Long Term Debt Total and its Total Stockholder Equity accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.

Short Long Term Debt Total vs Total Stockholder Equity

Short Long Term Debt Total vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nexalin Technology Short Long Term Debt Total account and Total Stockholder Equity. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Nexalin Technology's Short Long Term Debt Total and Total Stockholder Equity is -0.67. Overlapping area represents the amount of variation of Short Long Term Debt Total that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Nexalin Technology, assuming nothing else is changed. The correlation between historical values of Nexalin Technology's Short Long Term Debt Total and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt Total of Nexalin Technology are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Short Long Term Debt Total i.e., Nexalin Technology's Short Long Term Debt Total and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

-0.67

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Short Long Term Debt Total

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most indicators from Nexalin Technology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nexalin Technology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.Sales General And Administrative To Revenue is expected to rise to 54.81 this year, although the value of Selling General Administrative will most likely fall to about 4 M.

	2021	2022	2023	2024 (projected)
Interest Expense	82.3K	59.4K	38.8K	54.4K
Depreciation And Amortization	537.0	5.7K	4.3K	2.5K

Interest Expense Depreciation And Amortization

Nexalin Technology fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Long Term Debt
Total Assets		-0.47	0.37	0.16	0.95	0.84	0.72	-0.48	-0.71	0.23	0.38	0.43	0.37	1.0	0.07	0.26	-0.8	0.93	0.84	0.86	-0.01	1.0	-0.22	0.9	0.83	-0.79
Short Long Term Debt Total	-0.47		-0.04	0.55	-0.67	-0.85	0.24	0.94	0.86	0.46	-0.59	-0.99	-0.99	-0.43	-0.32	-0.75	0.74	-0.69	-0.86	-0.79	0.71	-0.45	0.95	-0.71	-0.87	0.62
Other Current Liab	0.37	-0.04		0.8	0.19	0.14	0.28	-0.31	-0.47	0.85	0.67	0.0	-0.02	0.38	0.76	-0.01	-0.63	0.28	0.21	0.48	0.67	0.37	0.25	0.49	0.15	-0.66
Total Current Liabilities	0.16	0.55	0.8		-0.12	-0.3	0.52	0.31	0.08	0.99	0.17	-0.59	-0.61	0.19	0.36	-0.45	-0.13	-0.07	-0.26	-0.01	0.98	0.17	0.78	0.06	-0.31	-0.23
Total Stockholder Equity	0.95	-0.67	0.19	-0.12		0.96	0.54	-0.63	-0.8	-0.04	0.38	0.65	0.6	0.94	0.05	0.49	-0.82	0.95	0.95	0.9	-0.3	0.95	-0.49	0.91	0.95	-0.76
Net Tangible Assets	0.84	-0.85	0.14	-0.3	0.96		0.28	-0.8	-0.89	-0.21	0.5	0.84	0.8	0.82	0.16	0.64	-0.85	0.92	1.0	0.93	-0.49	0.83	-0.7	0.9	1.0	-0.77
Property Plant And Equipment Net	0.72	0.24	0.28	0.52	0.54	0.28		0.25	-0.09	0.5	-0.17	-0.29	-0.35	0.76	-0.31	-0.23	-0.28	0.47	0.25	0.29	0.47	0.74	0.45	0.39	0.25	-0.28
Net Debt	-0.48	0.94	-0.31	0.31	-0.63	-0.8	0.25		0.93	0.19	-0.81	-0.95	-0.94	-0.44	-0.61	-0.7	0.84	-0.68	-0.84	-0.85	0.49	-0.46	0.83	-0.77	-0.82	0.79
Retained Earnings	-0.71	0.86	-0.47	0.08	-0.8	-0.89	-0.09	0.93		-0.03	-0.77	-0.85	-0.82	-0.69	-0.56	-0.7	0.96	-0.8	-0.93	-0.96	0.29	-0.7	0.66	-0.9	-0.91	0.9
Accounts Payable	0.23	0.46	0.85	0.99	-0.04	-0.21	0.5	0.19	-0.03		0.3	-0.49	-0.51	0.26	0.46	-0.37	-0.23	0.01	-0.16	0.1	0.94	0.24	0.71	0.16	-0.22	-0.35
Cash	0.38	-0.59	0.67	0.17	0.38	0.5	-0.17	-0.81	-0.77	0.3		0.6	0.59	0.35	0.9	0.3	-0.76	0.54	0.57	0.73	0.01	0.37	-0.4	0.7	0.51	-0.87
Non Current Assets Total	0.43	-0.99	0.0	-0.59	0.65	0.84	-0.29	-0.95	-0.85	-0.49	0.6		1.0	0.39	0.34	0.77	-0.7	0.65	0.85	0.77	-0.74	0.41	-0.96	0.68	0.85	-0.61
Non Currrent Assets Other	0.37	-0.99	-0.02	-0.61	0.6	0.8	-0.35	-0.94	-0.82	-0.51	0.59	1.0		0.33	0.35	0.77	-0.67	0.61	0.82	0.73	-0.75	0.36	-0.97	0.64	0.82	-0.58
Cash And Short Term Investments	1.0	-0.43	0.38	0.19	0.94	0.82	0.76	-0.44	-0.69	0.26	0.35	0.39	0.33		0.06	0.25	-0.79	0.91	0.81	0.83	0.03	1.0	-0.18	0.88	0.8	-0.77
Net Receivables	0.07	-0.32	0.76	0.36	0.05	0.16	-0.31	-0.61	-0.56	0.46	0.9	0.34	0.35	0.06		0.26	-0.55	0.16	0.25	0.45	0.24	0.07	-0.16	0.39	0.18	-0.66
Common Stock Shares Outstanding	0.26	-0.75	-0.01	-0.45	0.49	0.64	-0.23	-0.7	-0.7	-0.37	0.3	0.77	0.77	0.25	0.26		-0.53	0.31	0.65	0.52	-0.56	0.25	-0.72	0.38	0.66	-0.37
Non Current Liabilities Total	-0.8	0.74	-0.63	-0.13	-0.82	-0.85	-0.28	0.84	0.96	-0.23	-0.76	-0.7	-0.67	-0.79	-0.55	-0.53		-0.85	-0.89	-0.98	0.08	-0.8	0.49	-0.95	-0.86	0.94
Inventory	0.93	-0.69	0.28	-0.07	0.95	0.92	0.47	-0.68	-0.8	0.01	0.54	0.65	0.61	0.91	0.16	0.31	-0.85		0.92	0.93	-0.25	0.93	-0.49	0.97	0.91	-0.84
Other Current Assets	0.84	-0.86	0.21	-0.26	0.95	1.0	0.25	-0.84	-0.93	-0.16	0.57	0.85	0.82	0.81	0.25	0.65	-0.89	0.92		0.95	-0.45	0.83	-0.7	0.92	1.0	-0.82
Other Stockholder Equity	0.86	-0.79	0.48	-0.01	0.9	0.93	0.29	-0.85	-0.96	0.1	0.73	0.77	0.73	0.83	0.45	0.52	-0.98	0.93	0.95		-0.22	0.85	-0.57	0.99	0.93	-0.94
Total Liab	-0.01	0.71	0.67	0.98	-0.3	-0.49	0.47	0.49	0.29	0.94	0.01	-0.74	-0.75	0.03	0.24	-0.56	0.08	-0.25	-0.45	-0.22		0.0	0.89	-0.14	-0.49	-0.03
Total Current Assets	1.0	-0.45	0.37	0.17	0.95	0.83	0.74	-0.46	-0.7	0.24	0.37	0.41	0.36	1.0	0.07	0.25	-0.8	0.93	0.83	0.85	0.0		-0.21	0.9	0.82	-0.78
Short Term Debt	-0.22	0.95	0.25	0.78	-0.49	-0.7	0.45	0.83	0.66	0.71	-0.4	-0.96	-0.97	-0.18	-0.16	-0.72	0.49	-0.49	-0.7	-0.57	0.89	-0.21		-0.47	-0.72	0.36
Common Stock	0.9	-0.71	0.49	0.06	0.91	0.9	0.39	-0.77	-0.9	0.16	0.7	0.68	0.64	0.88	0.39	0.38	-0.95	0.97	0.92	0.99	-0.14	0.9	-0.47		0.9	-0.94
Property Plant Equipment	0.83	-0.87	0.15	-0.31	0.95	1.0	0.25	-0.82	-0.91	-0.22	0.51	0.85	0.82	0.8	0.18	0.66	-0.86	0.91	1.0	0.93	-0.49	0.82	-0.72	0.9		-0.77
Long Term Debt	-0.79	0.62	-0.66	-0.23	-0.76	-0.77	-0.28	0.79	0.9	-0.35	-0.87	-0.61	-0.58	-0.77	-0.66	-0.37	0.94	-0.84	-0.82	-0.94	-0.03	-0.78	0.36	-0.94	-0.77

Click cells to compare fundamentals

Nexalin Technology Account Relationship Matchups

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Nexalin Technology is a strong investment it is important to analyze Nexalin Technology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nexalin Technology's future performance. For an informed investment choice regarding Nexalin Stock, refer to the following important reports:

How To Invest In Nexalin

Details

Is Nexalin Stock a good investment?

Details

What is Nexalin Technology's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.

You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.65)

Revenue Per Share

0.02

Quarterly Revenue Growth

(0.24)

Return On Assets

(1.19)

Return On Equity

(2.02)

The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nexalin Short Long Term Debt Total vs Total Stockholder Equity Analysis

Short Long Term Debt Total vs Total Stockholder Equity

Short Long Term Debt Total vs Total Stockholder Equity Correlation Analysis

Correlation Coefficient

Short Long Term Debt Total

Total Stockholder Equity

Nexalin Technology fundamental ratios Correlations

Nexalin Technology Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Other Current Assets	+ 1.0	Net Tangible Assets
Property Plant Equipment	+ 1.0	Net Tangible Assets
Non Currrent Assets Other	+ 1.0	Non Current Assets Total
Total Current Assets	+ 1.0	Cash And Short Term Investments

Non Currrent Assets Other	- 0.99	Short Long Term Debt Total
Non Current Assets Total	- 0.99	Short Long Term Debt Total
Other Stockholder Equity	- 0.98	Non Current Liabilities Total
Short Term Debt	- 0.97	Non Currrent Assets Other
Short Term Debt	- 0.96	Non Current Assets Total
Other Stockholder Equity	- 0.96	Retained Earnings